Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550
تيراداين إنك
Teradyne, Inc. TER | 0.00 |
Cantor Fitzgerald analyst C.J. Muse maintains Teradyne (NASDAQ:
TER) with a Overweight and raises the price target from $400 to $550.
